Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.

Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.

Fifteen women with severe vertebral osteoporosis were treated with daily parathyroid peptide (hPTH) plus hormone-replacement co-therapy (HRT) for 1 year. Eight other patients were randomized to HRT alone. Co-therapy with hPTH and HRT resulted in an impressive mean treatment response at the spine (du...

Descripció completa

Dades bibliogràfiques
Autors principals:	Reeve, J, Mitchell, A, Tellez, M, Hulme, P, Green, JR, Wardley-Smith, B, Mitchell, R
Format:	Journal article
Idioma:	English
Publicat:	2001

Ítems similars

Human parathyroid peptide treatment of vertebral osteoporosis.
per: Reeve, J, et al.
Publicat: (1993)

Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
per: Reeve, J, et al.
Publicat: (1987)

A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
per: Reeve, J, et al.
Publicat: (1986)

Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
per: Tellez, M, et al.
Publicat: (1995)

Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
per: Scoutellas, V, et al.
Publicat: (1999)

Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
per: Merih Özgen, et al.
Publicat: (2017-08-01)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
per: Lundkvist, J, et al.
Publicat: (2006)

The Impact of Vertebral Fractures on Quality of Life in Postmenopausal Osteoporosis
per: Hakan Nur, et al.
Publicat: (2011-12-01)

THE INFLUENCE OF POSTMENOPAUSAL OSTEOPOROSIS AND SUBCLINICAL VERTEBRAL FRACTURES ON POSTMENOPAUSAL WOMEN’S QUALITY OF LIFE
per: L. A. Marchenkova, et al.
Publicat: (2016-02-01)

Clinical and laboratory comparison in postmenopausal osteoporosis with normal and enhanced function of the parathyroid glands
per: K. A. Saveleva, et al.
Publicat: (2015-06-01)

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
per: K A Maslova, et al.
Publicat: (2008-06-01)

Yearly zoledronic acid in postmenopausal osteoporosis.
per: Poole, K, et al.
Publicat: (2007)

POSSIBILITY OF PHARMACOLOGICAL CORRECTION OF POSTMENOPAUSAL OSTEOPOROSIS IN PATIENTS WITH EXTRAARTICULAR FRACTURES OF THE PROXIMAL FEMUR
per: A. Y. Kochish, et al.
Publicat: (2011-06-01)

Impact of vitamin D deficiency on fluctuation of calcium and parathyroid hormone levels in postmenopausal osteoporosis
per: Tatjana Milivojac, et al.
Publicat: (2015-06-01)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
per: Esteban Jódar-Gimeno
Publicat: (2007-04-01)

Dietary determinants of post-menopausal bone loss at the lumbar spine: a possible beneficial effect of iron.
per: Abraham, R, et al.
Publicat: (2006)

Pathogenesis and treatment of postmenopausal osteoporosis
per: Milhaud, G, et al.
Publicat: (1983)

Hormone replacement therapy in prevention and treatment of postmenopausal osteoporosis
per: Rajesh Hishikar, et al.
Publicat: (2014-01-01)

The Effects of Parathyroid Hormone Applied at Different Regimes on the Trochanteric Region of the Femur in Ovariectomized Rat Model of Osteoporosis
per: M. Tezval, et al.
Publicat: (2011-01-01)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
per: Virgínia Fernandes Moça Trevisani, et al.

Dynamic Spine Hyperflexion Is Related to Vertebral Compression Fractures in Postmenopausal Women
per: Zhirong Zheng, et al.
Publicat: (2023-01-01)

Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.
per: Arlot, M, et al.
Publicat: (1993)

Salivary biomarkers (Vitamin D, Calcium, and Estrogen Hormone) in postmenopausal women with osteoporosis
per: Ameera Y AL-Amiry, et al.
Publicat: (2023-01-01)

The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
per: Hesp, R, et al.
Publicat: (1981)

Relationship Between Patient’s Age and Bone Mineral Density of Lomber Spine and Femur in Postmenopausal Women
per: Taciser Kaya, et al.
Publicat: (2003-09-01)

Use of estrogen replacement therapy in menopause: Secondary prevention of osteoporosis
per: Đurica Snežana
Publicat: (2007-01-01)

Osteoblast density and the evolution of BMUs in vertebral osteoporosis
per: Brown, M, et al.
Publicat: (1993)

Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis.
per: Deacon, A, et al.
Publicat: (1987)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
per: Silvia Migliaccio, et al.
Publicat: (2007-04-01)

Bone remodelling does not decline after menopause in vertebral fracture osteoporosis.
per: Wand, J, et al.
Publicat: (1992)

Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α
per: Guangfei Li, et al.
Publicat: (2025-01-01)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
per: Luigi Gennari, et al.
Publicat: (2010-01-01)

When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS).
per: Kaptoge, S, et al.
Publicat: (2004)

Determinants of the first decade of bone loss after menopause at spine, hip and radius.
per: Reeve, J, et al.
Publicat: (1999)

Parathyroid Hormone in Osteoporosis Treatment
per: İ. Özkul
Publicat: (2002-03-01)

A case of atypical femur fracture during long-term treatment with bisphosphonates in patient with postmenopausal osteoporosis
per: Kira E. Zotkina, et al.
Publicat: (2019-11-01)

Qualitative analysis of serum estrogen, parathyroid and calcium levels in postmenopausal women with oral dryness- A case-control study
per: Balwinder Singh, et al.
Publicat: (2020-01-01)

HIP REPLACEMENT FOR HIP FRACTURES AND THEIR CONSEQUENCES IN POSTMENOPAUSAL OSTEOPOROSIS IN MULTIPAROUS WOMEN
per: A.A. RAZZOKOV, et al.
Publicat: (2019-12-01)

Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus
per: Youhua Xu, et al.
Publicat: (2014-07-01)

Mineral bone density association with estrogen alpha receptor gene (ESRa) polymorphisms at postmenopausal osteoporosis
per: M Y Krylov, et al.
Publicat: (2005-02-01)